baber/WOPTO huggingface dataset:
Patent AU-612632-B2 (AU)
Title: Amorphous silicas
Inventor: ALDCROFT DEREK
IPC: C01B33/12
Filed: 1988-03-28
Granted: 1991-07-18
Abstract: An amorphous silica suitable for use as a stabiliser for alcoholic beverages, eg beers, has a pore volume from about 1.6 to 2.5 cc g<-><1>, a mean pore diameter from about 8.5 to 14.0 nm and a surface area of at least 450 m<2>g<-><1>. The silica may be prepared by a precipitation route in which sodium silicate is mixed with mineral acid in the presence of electrolyte at a temperature of from 20 DEG C to 50 DEG C.
Patent AU-570636-B2 (AU)
Title: Electric hotplate
Inventor: FISCHER KARL
IPC: H05B3/68
Filed: 1983-06-20
Granted: 1988-03-24
Abstract: An electric hotplate has a hotplate body with a closed cooking surface made from an iron-based sintered material with additions of other metals. The sintered material hotplate body has a plurality of narrow, flat slots on its bottom, in which is inserted an uncoiled, slightly undulating heating resistor wire. According to a variant, said heating resistor comprises a strip.
Patent AU-669833-B2 (AU)
Title: Inhibition of restenosis by ultraviolet radiation
Inventor: CLARKE RICHARD H
IPC: A61B17/22
Filed: 1995-04-19
Granted: 1996-06-20
Abstract: Restenosis following angioplasty can be inhibited by reducing the proliferation of smooth muscle cells in the blood vessel walls at an angioplasty site, and such reduction in cell proliferation can be accomplished by an apparatus which irradiates the angioplasty site with radiation in the ultraviolet (UV) wavelength range. The ultraviolet radiation is preferably delivered via an optical fiber or other waveguide incorporated, for example, into a percutaneous catheter. In operation, the ultraviolet radiation kills smooth muscle cells at the site, thereby reducing the risk of restenosis, while minimising damage to surrounding tissue. <IMAGE>
Patent AU-734508-B2 (AU)
Title: Transport and storage container
Inventor: LAARHOVEN HANS
IPC: B65D6/22
Filed: 1997-01-25
Granted: 2001-06-14
Abstract: The container has a rectangular base (30) and four side walls (10, 20). When the container is empty, the top of each wall is folded inwards about a pivot axis parallel to the base edges. Two opposite first walls have curved corner sections (11). These, and the second side walls, have overlapping connection sections (12, 22) of a thickness, which is reduced by approx. 50%. The base has plinth parts (31), with rounded corner sections. Two opposite second side walls (20) have sideward projecting shoulders (21), which are positioned between the base and the round wall corners, when the walls are upright.
Patent AU-609675-B2 (AU)
Title: Calcium-iron mineral supplements
Inventor: MEHANSHO HALE
IPC: A23L1/304
Filed: 1988-07-01
Granted: 1991-05-02
Abstract: Nutritional mineral supplements comprise a mixture of a calcium source, especially calcium citrate-malate, and an iron-sugar complex, especially iron sucrate-malate. Food and beverage compositions, especially juice beverages, supplemented with these calcium and iron materials are disclosed.
Patent AU-733913-B2 (AU)
Title: Human epithelial colon immortalised cell line
Inventor: BLUM STEPHANIE
IPC: C12Q1/00
Filed: 1997-04-17
Granted: 2001-05-31
Abstract: Immortalised human colon epithelial cell line has no tumour markers, expresses metabolic markers specific for non-immortalised human epithelial cells, expresses differentiation markers specific for non-immortalised human colon epithelial cells, and is capable of adhering to lactic acid bacterium CNCM I-1225 in vitro. Also claimed are: (1) a serum-free culture medium for culturing and immortalising human colon epithelial cells, containing inorganic salts, glucose, sodium pyruvate, amino acids, bovine serum albumin, ethanolamine, phosphoethanolamine, vitamins (vitamin C and retinoic acid), trace elements and hormones (triiodothyronine, dexamethasone, hydrocortisone, bovine pituitary extract, insulin, epithelial growth factor and transferrin), and (2) a process for immortalising human colon epithelial cells, comprising preparing a primary culture of the cells, infecting the culture with a recombinant virus, and culturing the cells in a medium as above.
Patent AU-586959-B2 (AU)
Title: An echo compensator
Inventor: PFEIL DIRSKO V
IPC: H04B3/23
Filed: 1988-07-28
Granted: 1989-07-27
Abstract: The step width with which a transversal filter (21) in the echo canceller (10) is set is also dependent on the size of the error signal (F) at the transmission path output (13). As a result, when a large signal (F) occurs, the echo canceller (10) quickly compensates with a large step width for the echo which causes the greatest interference and subsequently, when a smaller error signal (F) occurs, effectively cancels the residual echo with a smaller step width. In the case of duplex operation which cannot be reliably identified, a large signal is simulated. The aim is to prevent this effect. An echo measuring device (26) identifies duplex operation with relative reliability and sends a step width setting signal (S) to the transversal filter (21). A frame adaptation memory (28) detects a phase shift or slip and then resets the echo measuring device (26) with a reset signal (R). The echo canceller is used in international gateway exchanges. <IMAGE>
Patent AU-690241-B2 (AU)
Title: Agent for treating hepato-biliary diseases
Inventor: UENO RYUJI
IPC: A61K31/5575
Filed: 1995-06-01
Granted: 1998-04-23
Abstract: The object of the present invention is to provide a pharmaceutical composition for treatment of hepato.biliary disease reduced in side effect such as diarrhea, which comprises 16,16-difluoro-15-keto-PGs having at least one methyl group or ethyl group on the carbon atom at the 17- or 18-position or adjacent to the terminal methyl group of omega -chain as an essential component.
Patent AU-716724-B2 (AU)
Title: A latent mercaptan as a heat stabilizer
Inventor: DUVALL TOD CHARLES
IPC: C08L101/04
Filed: 1999-03-18
Granted: 2000-03-02
Abstract: Flexible, semi-rigid, and rigid vinyl chloride polymer compositions comprising a latent mercaptan-containing heat stabilizer are substantially free from the offensive odour typically associated with mercaptans and are protected during processing by the degradation products of the latent (i.e., blocked) mercaptan which include a free mercaptan. The free mercaptan thus released enhances the activity of metallic-based heat stabilizers such as zinc carboxylates and organotin carboxylates and mercaptides in the polymer composition. Other products of the degradation are believed to include carbocations of the blocking moiety which are stabilized by a molecular structure in which the electron deficiency is shared by several groups. The latent mercaptan is selected from a 2-S-(tetrahydropyranyl)-thioalkanol, a carboxylic acid ester thereof, a 2-S-(tetrahydropyranyl)-thioglycolic acid, and an ester thereof.
Patent AU-723110-B2 (AU)
Title: Human beta 2 integrin alpha subunit
Inventor: GALLATIN MICHAEL W
IPC: C12Q1/68
Filed: 1997-02-24
Granted: 2000-08-17
Abstract: Monoclonal antibodies, and hybridomas that express the antibodies, which are immunospecific for a novel human  beta 2 integrin alpha subunit polypeptide are disclosed.
Patent AU-735533-B2 (AU)
Title: Method for producing alkoxylated dimer fatty acids
Inventor: RATHS HANS-CHRISTIAN
IPC: C07C67/26
Filed: 1998-12-04
Granted: 2001-07-12
Abstract: Processes for preparing alkylene glycol esters of dimer fatty acids according to the general formula (I):wherein R1 represents a hydrocarbon radical of a dimer fatty acid having from about 24 to about 44 carbon atoms, and each R independently represents an alkyl radical having from about 2 to about 3 carbon atoms, and each n independently represents a number of from about 0.25 to about 3.0, are described. The processes include: (a) providing dimer fatty acids; (b) providing an alkylene oxide; and (c) reacting the dimer fatty acids and the alkylene oxide, in the presence of a catalytically-effective amount of at least one alkanolamine.
Patent AU-670033-B2 (AU)
Title: Solubility parameter based drug delivery system and method for altering drug saturation concentration
Inventor: MIRANDA JESUS
IPC: A61F13/00
Filed: 1992-06-22
Granted: 1996-07-04
Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.
Patent AU-662165-B2 (AU)
Title: Ceramide and/or glycoceramide-based cationic dispersions
Inventor: DUBIEF CLAUDE
IPC: A61K8/64
Filed: 1992-07-30
Granted: 1995-08-24
Abstract: Cationic dispersion containing at least: 1) a ceramide or glycoceramide or a blend of natural or synthetic ceramides and/or glycoceramides of the formula (I) in which R1? is a C14?-C30? alkyl; R2? is hydrogen, (glycosyl)n?, (galactosyl)m? or sulphogalactosyl; n is 1 to 4, m is 1 to 8; R3? is a C15?-C26? hydrocarbonated radical or a C15?-C26? $g(a)-hydroxyalkyl in the case of natural ceramides and/or glycoceramides; 2) a compound of the formula (II) in which X is an anion and a) R4?, R5?, R6? are a C1?-C4? alkyl, R7? is a C22? alkyl, or b) R4? and R5? are a C1?-C4? alkyl and (i) R6? and R7? are a C10?-C22? alkyl; or (ii) R6? is a C22? alkyl, R7? is benzyl; or c) R4? is a C1?-C4? alkyl, R5? is an (alkyl and/or alkenyl)amidoethyl; R6? and R7? are 4,5-dihydroimidazole substituted in position 2 by a C13?-C21? alkyl and/or alkenyl.
Patent AU-604172-B2 (AU)
Title: Improved gasket and method of making same
Inventor: MCDOWELL DONALD J
IPC: F16J15/10
Filed: 1988-11-18
Granted: 1990-12-06
Abstract: A gasket such as a cylinder head gasket (10) molded of an amorphous fiber reinforced thermoplastic resin composite having at least 3% by weight of reinforcing fibers, and having an integral non-elastomeric sealing bead (30) extending above the gasket body (12) and surrounding at least one service opening (16) and a method of making such a gasket.
Patent AU-611238-B2 (AU)
Title: Device for coupling a metallurgical ladle to a gas supply
Inventor: STOMP HUBERT
IPC: C21C7/072
Filed: 1988-12-19
Granted: 1991-06-06
Abstract: An apparatus for coupling a metallurgical ladle to a gas supply is presented wherein gas is used for the treatment of molten metal contained in the ladle. The gas is injected through the bottom of the ladle into the liquid metal. The ladle rests on a support located at a treatment station. The apparatus comprises a base mounted on the bottom of the ladle support in a manner as to be slidable in two directions at right angles to one another against the action of springs. The apparatus is provided with a male connection head which has an axial through passage that communicates with the gas supply. This apparatus also includes a foot fixed on the ladle which is provided with a female connection member for engagement on the connection head when the ladle is placed in its support.
Patent AU-661058-B2 (AU)
Title: Piperazic acid derivatives as collagenase inhibitor
Inventor: SUGIMURA YUKIO
IPC: A61K31/501
Filed: 1992-11-02
Granted: 1995-07-13
Abstract: Constitution: a novel compound represented by general formula (1), wherein R<1> represents -OR<3> (R<3> being H or alkyl), -NR<4>R<5> (R<4> and R<5> being each H, alkyl or alkoxy), -NHCH(R<6>)COR<7> (R<6> being H or alkyl, and R<7> being alkyl), -NHCH(R<6>)COOR<8>(R<8> being alkyl) or -NHCH(R<6>)CONR<9>R<1><0> (R<9> and R<1><0> being each H or alkyl, or alternatively NR<9>R<1><0> being a heterocyclic group as a whole); and R<2> represents H, alkyl or aralkyl. Effect: since the compound has an inhibitory activity type IV collagenase, it is useful as an inhibitor against vascularization, cancer infiltration or cancer metastasis. <CHEM>
Patent AU-563380-B2 (AU)
Title: Deodorisation process for triglyceride oils
Inventor: MERCK WERNER
IPC: B01D5/00
Filed: 1984-05-22
Granted: 1987-07-09
Abstract: Process and apparatus for deodorising triglyceride oil comprises passing dry steam through the oil, the oil being at a temperature between 160 and 280 DEG C and under a pressure of between 0.1 to 8.0 mbar and condensing by indirect condenser means a vapour phase having a Reynolds number less than 2300 and comprising steam, volatile materials from the oil and less than 100 mg neutral oil per m<3> of steam when measured under the conditions prevailing in the headspace above the oil. The condensate can be solid or liquid form. In either case the condensate can be readily drained from the condenser.
Patent AU-672378-B2 (AU)
Title: Fungistatic method and composition employing type II endoglycosidases and/or peroxidases and/or chitinases
Inventor: ASHIZAWA EUNICE C
IPC: A01N63/50
Filed: 1992-12-08
Granted: 1996-10-03
Abstract: The invention relates to a fungistatic composition comprising a peroxidase selected from the group consisting of manganese (II) peroxidase, lignin peroxidase and horseradish peroxidase either alone or in combination with a plant chitinase selected from the group consisting of corn, wheat germ, tomato stem, bean leaf, soybean seed, melon plant, cucumber leaf, barley seed and pea pod chitinase and a fungistatic method comprising contacting a fungus, or a plant, fruit or vegetable containing such fungus with a fungistatic effective amount of said composition.
Patent AU-619829-B2 (AU)
Title: Transporting a liquid past a barrier
Inventor: FRAY DEREK JOHN
IPC: C25C3/00
Filed: 1989-03-21
Granted: 1992-02-06
Abstract: The invention provides a method of transporting a liquid A past or around a barrier, by adding a solute S to liquid A on one side of the barrier and correspondingly removing solute S from liquid A on the other side of the barrier, the solute S being such as to change the density of the liquid A when dissolving in it, thereby providing a motive force for its motion around the barrier. An example of the application of the invention is in a two-part electrolytic cell (1) comprising electrowinning and electrofining half cells (2 and 3, respectively), wherein the metal, solute S, is electrowon into a liquid (16,16a), liquid A, on one side of the cell's common electrode (4), the barrier, in the electrowinning half cell (2), and electrolytically removed from the liquid (17,17a) on the other side of the common electrode (4), in the electrorefining half cell (3).
Patent AU-711236-B2 (AU)
Title: Telephone polling method
Inventor: WEISSER FRANK J JR
IPC: H04Q3/00
Filed: 1997-06-24
Granted: 1999-10-07
Abstract: In an intelligent switched telephone network, a telephone polling method is provided wherein a call made in response to a telephone based polling service is processed and disconnected without connection of the call to the subscriber of the polling service. A call received in the network and directed to a number associated with a telephone polling service has its identification information read and compared to entries in a database of subscriber information for a matching entry. The call is tabulated in the database as a response to the polling service poll or survey. If desired by the polling service subscriber, the calling party may be provided with a caller interaction program through which the calling party may select from a variety of responses. If desired, the calling party may be provided with a call termination announcement.  <IMAGE>
Patent AU-667076-B2 (AU)
Title: Water-in-oil emulsions
Inventor: JAHNKE RICHARD WILLIAM
IPC: C06B47/00
Filed: 1993-03-16
Granted: 1996-03-07
Abstract: This invention is directed to water-in-oil emulsions which are useful as explosives. These emulsions comprise: a discontinuous aqueous phase comprising at least one oxygen-supplying component; a continuous organic phase comprising at least one carbonaceous fuel; and a minor emulsifying amount of at least one emulsifier. The emulsifier is the product made by the reaction of component (A) with component (B), component (A) being at least one substituted succinic acylating agent, said substituted succinic acylating agent consisting of substituent groups and succinic groups wherein the substituent groups are derived from a polyalkene, said acylating agents being characterized by the presence within their structure of an average of at least 1.3 succinic groups for each equivalent weight of substituent groups, and component (B) being ammonia and/or at least one amine.
Patent AU-720354-B2 (AU)
Title: Frozen food with antifreeze peptides
Inventor: FENN RICHARD ANTHONY
IPC: A23G9/42
Filed: 1997-07-04
Granted: 2000-06-01
Abstract: A process for the production of a frozen food product comprising AFP, wherein the conditions are chosen such that the ice-crystals in the product have an aspect ratio of from 1.9 to 3.
Patent AU-778447-B2 (AU)
Title: Hydrogen reduction of sulfonyl chlorides to thiols
Inventor: JACOBSON STEPHEN E
IPC: C07C321/26
Filed: 2001-02-26
Granted: 2004-12-02
Abstract: This invention relates to a process for the production of an aryl thiol, which comprises hydrogenating an aryl sulfonyl chloride in a solvent in the presence of a palladium catalyst and a base whose conjugate acid has a pKa of about 2 or greater, wherein the base is selected from the group consisting of ionic bases soluble in water and tertiary amines soluble in the solvent, the tertiary amines not having a methyl group attached to the amine nitrogen.
Patent AU-656298-B2 (AU)
Title: Flame retardant compositions
Inventor: KEOGH MICHAEL JOHN
IPC: C03C25/10
Filed: 1993-06-21
Granted: 1995-01-27
Abstract: A composition comprising:   (a) polyethylene having a density equal to or less than 0.925 gram per cubic centimeter, grafted with an unsaturated aliphatic diacid anhydride; and (b) magnesium hydroxide, surface treated with a saturated or unsaturated carboxylic acid or a metal salt thereof in an amount of about 0.1 to about 1 part by weight of acid or salt per 100 parts by weight of magnesium hydroxide.
Patent AU-669944-B2 (AU)
Title: Iron stabilizers for 3-isothiazolones
Inventor: MATTOX JOHN ROBERT
IPC: C09K15/02
Filed: 1994-01-04
Granted: 1996-06-27
Abstract: A method of preparing a stable, dilute aqueous solution of at least one 3-isothiazolone compound comprising 5-chloro-2-methyl-3-isothiazolone, the concentration of said compound(s) in said solution being about 0.5 to 5% by weight based on solution, comprising introducing about 0.1 to 5% by weight based on said solution, of a ferric salt as the stabilizer is disclosed. Dilute aqueous solutions of about 0.5 to 5.0 parts by weight of at least one 3-isothiazolone compound comprising 5-chloro-2-methyl-3-isothiazolone, about 0.1 to 2.5 parts by weight of a stabilizing, water soluble, non-chelated ferric salt, and about 92 to 99 parts by weight of aqueous solvent, are also disclosed.
Patent AU-770495-B2 (AU)
Title: Medicinal compositions for preventing or treating viral myocarditis
Inventor: MATSUMORI AKIRA
IPC: A61K31/137
Filed: 2000-06-28
Granted: 2004-02-26
Abstract: The present invention aims at providing a pharmaceutical composition for the prophylaxis or treatment, irrespective of the kind of virus, of viral myocarditis or-viral diseases induced by viral myocarditis, by the treatment or prevention of the onset of cytotoxicity in various organs, and a method of the prophylaxis or treatment. The present invention also relates to a pharmaceutical composition for the prophylaxis or treatment of viral myocarditis or viral diseases induced by viral myocarditis, which contains 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol or a pharmacologically acceptable salt thereof as an active ingredient. The present invention further relates to a method for the prophylaxis or treatment of viral myocarditis or viral diseases induced by viral myocarditis, which includes administering an effective amount of the aforementioned compound or a pharmacologically acceptable salt thereof.
Patent AU-538771-B2 (AU)
Title: Wet steam turbine
Inventor: RITZI EMIL WILHELM
IPC: F01D1/00
Filed: 1980-02-29
Granted: 1984-08-30
Abstract: A turbine has a first nozzle means (34, 35, 36) for discharging fluid including vapor and liquid and a rotor (24, see Figures 1 and 2) to receive fluid supplied via the first nozzle means and for forming a ring of liquid (50). The rotor (24) acts as a vapor/liquid separator and a turbine rotor, the rotor having first vanes (42) to receive and pass the liquid and thereby drive the rotor and exit nozzles (47) to which liquid subjected to centrifugal pressurization in the ring of liquid (50) is delivered, the exit nozzles (47) being angled to form exit jets producing further thrust acting to drive the rotor. The invention provides an economical prime mover of low capital cost due to simple construction, high reliability, and minimum maintenance requirements.
Patent AU-727357-B2 (AU)
Title: Spinner-type fishing lures and wire and cable fishing leaders
Inventor: JOHNSON WILLIAM B
IPC: A01K91/14
Filed: 1997-12-05
Granted: 2000-12-14
Abstract: An improved fishing lure employing a wire frame (10) having first (14) and second arms (16) that extend in divergent directions with respect to each other. A fish attracting element (18) and a hook (20) are secured to one arm (14), and a spinner (32) is attached to the other arm (16). The wire frame is formed of a nickel titanium alloy which provides flexibility and shape memory that are substantially greater than that provided by conventional stainless steel wire whereby when the lure is pulled through water, it has improved fish attracting action. Wire and cable fishing leaders formed of a nickel titanium alloy are disclosed which exhibit appreciable elongation and resistance to kinking and spiralling.
Patent AU-742095-B2 (AU)
Title: A process for manufacturing, by molding non-resinous organic and inorganic compositions
Inventor: TAYLOR DEREK
IPC: B27N3/00
Filed: 1996-07-05
Granted: 2001-12-20
Abstract: A rigid shaped product is produced from organic or inorganic solid particulate materials, preferably waste materials by mixing the solid particulate materials with a non-toxic composed of an aqueous dispersion of a blend of acrylic and polyurethane resin which forms a self-crosslinking composition resin material in a thermoplastic state to form a flowable mixture. The flowable mixture is then formed into a desired shape such as a flat panel or sheet, by molding, extrusion, or injection molding, and cured to thermoset the resin material and form a rigid, shaped product such as a construction board.
Patent AU-673253-B2 (AU)
Title: Process for producing liquid pig iron from lump iron ore
Inventor: VULETIC BOGDAN
IPC: C21B13/14
Filed: 1994-05-27
Granted: 1996-10-31
Abstract: A process for the direct production of sponge iron particles and liquid pig iron from iron ore pellets is described, in which the iron ore is reduced as a loose fill (bed) in a direct-reduction unit by means of hot reduction gases to give sponge iron and is then smelted, in a smelting gasifier, by means of introduced carbon and injected oxygen-containing gas, reduction gas being generated at the same time. At least a portion of the reduction gas, having been cooled to the temperature required for the reduction, is passed into the reduction zone of the direct-reduction unit. A considerable fraction of the carbon and of the reduction gas is due to the initial presence of a mixture of hydrocarbon-containing plastic and petroleum coke and/or coke (breeze). The reduction gases are primarily produced, at least in part, by cracking (from the plastic) and by thermal gasification (from the coke).